Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.92
Delayed Data
As of Feb 11
 +0.03 / +1.04%
Today’s Change
2.65
Today|||52-Week Range
6.76
-27.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues12.5K12.5K12.5K32.5K
 
 
 
 
 
Depreciation And Amortization226.9K223.9K219.0K223.2K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses8.7M10.8M10.6M10.1M
 
 
 
 
 
Research And Development4.7M6.6M6.7M6.6M
 
 
 
 
 
Total Operating Expenses8.9M11.0M10.8M10.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.9M-11.0M-10.8M-10.3M
 
 
 
 
 
Extraordinary Credit700.0K--0.000.00
 
 
Interest Expense On Debt122.00--0.000.00
 
 
Other Expenses-58.4K-57.6K177.9K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.1M-10.9M-10.6M-10.0M
 
 
 
 
 
Net Income-8.1M-10.9M-10.6M-10.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.7M41.9M41.9M42.0M
 
 
 
 
 
Shares To Calculate EPS Diluted41.7M41.9M41.9M42.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.26-$0.25-$0.24
 
 
 
 
 
EPS Diluted-$0.19-$0.26-$0.25-$0.24